Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis (Q40533104)
Jump to navigation
Jump to search
scientific article published on August 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis |
scientific article published on August 2004 |
Statements
1 reference
Cyclooxygenase (COX)-2 inhibitor celecoxib abrogates TNF-induced NF-kappa B activation through inhibition of activation of I kappa B alpha kinase and Akt in human non-small cell lung carcinoma: correlation with suppression of COX-2 synthesis (English)
1 reference
Shishir Shishodia
1 reference
Dimpy Koul
1 reference
Bharat B Aggarwal
1 reference
1 August 2004
1 reference
1 reference
Identifiers
1 reference